1. Graves' disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy;Antonelli A, Fallahi P, Elia G, Ragusa F, Paparo SR, Ruffilli I;Best Pract Res Clin Endocrinol Metab,2020
2. Diagnostic Utility of Mean Peak Systolic Velocity of Superior Thyroid Artery in Differentiating Graves’ Disease from Thyroiditis;Sarangi PK, Parida S, Mangaraj S, Mohanty BK, Mohanty J, Swain BM;Indian J Radiol Imaging,2021
3. Thyroid vascularization is an important ultrasonographic parameter in untreated Graves' disease patients;Vita R, Di Bari F, Perelli S, Capodicasa G, Benvenga S;J Clin Transl Endocrinol,2019
4. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report;Ohara N, Kaneko M, Kitazawa M, Uemura Y, Minagawa S, Miyakoshi M;J Med Case Rep,2017
5. Hyperthyroid Graves’ disease without detectable thyrotropin receptor antibodies;Ilicki A, Gamstedt A, Karlsson FA;J Clin Endocrinol Metab,1992